A Platform Approach to Functional Potency Assay Development for Gene Therapy Products

Originally Presented:
Wednesday, November 20, 2019
Analytical Development Summit
Boston, MA

Presenter: Karen Doucette, MBA
Director of Operations, ACF Bioservices

What you will learn:

  • Streamlining development of functional potency assays across diverse product types with custom and complex MOA
  • Bridging the gap between R&D and cGMP for commercially viable potency assays
  • Case studies for in vivo and ex vivo and non-vector based therapies